- Home
- BVFL vs BIOA Comparison
BVFL vs BIOA Comparison
Compare BVFL & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BVFL
- BIOA
- Stock Information
- Founded
- BVFL 1873
- BIOA 2015
- Country
- BVFL United States
- BIOA United States
- Employees
- BVFL N/A
- BIOA N/A
- Industry
- BVFL Savings Institutions
- BIOA Biotechnology: Pharmaceutical Preparations
- Sector
- BVFL Finance
- BIOA Health Care
- Exchange
- BVFL Nasdaq
- BIOA Nasdaq
- Market Cap
- BVFL 150.2M
- BIOA 155.2M
- IPO Year
- BVFL N/A
- BIOA 2024
- Fundamental
- Price
- BVFL $16.25
- BIOA $4.55
- Analyst Decision
- BVFL
- BIOA Hold
- Analyst Count
- BVFL 0
- BIOA 4
- Target Price
- BVFL N/A
- BIOA $5.67
- AVG Volume (30 Days)
- BVFL 44.9K
- BIOA 91.6K
- Earning Date
- BVFL 07-17-2025
- BIOA 08-06-2025
- Dividend Yield
- BVFL N/A
- BIOA N/A
- EPS Growth
- BVFL 27.12
- BIOA N/A
- EPS
- BVFL 1.07
- BIOA N/A
- Revenue
- BVFL $38,333,000.00
- BIOA $3,863,000.00
- Revenue This Year
- BVFL N/A
- BIOA N/A
- Revenue Next Year
- BVFL N/A
- BIOA N/A
- P/E Ratio
- BVFL $15.31
- BIOA N/A
- Revenue Growth
- BVFL 2.48
- BIOA N/A
- 52 Week Low
- BVFL $13.53
- BIOA $2.88
- 52 Week High
- BVFL $18.19
- BIOA $26.62
- Technical
- Relative Strength Index (RSI)
- BVFL 60.81
- BIOA N/A
- Support Level
- BVFL $15.18
- BIOA N/A
- Resistance Level
- BVFL $16.72
- BIOA N/A
- Average True Range (ATR)
- BVFL 0.34
- BIOA 0.00
- MACD
- BVFL 0.08
- BIOA 0.00
- Stochastic Oscillator
- BVFL 69.87
- BIOA 0.00
About BVFL BV Financial Inc.
BV Financial Inc is a federally-chartered savings and loan holding company engaged in offering traditional financial services to consumers and businesses. The company offers savings, interest checking, money market, personal and business checking, non-interest checking, education savings, small business checking, and business checking and certificates of deposit and IRA certificates of deposit. The Company's sources of revenue are derived from interest and dividends earned on loans and investment securities.
About BIOA BioAge Labs Inc. Common Stock
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.